Quantum Biopharma Ltd. | WebDisclosure

Basculer en Français

10161	Companies
208730	Keywords
138855	Articles
110646	Press releases

Headlines Articles Press releases Quantum Biopharma Ltd.

Home
Companies
Quantum Biopharma Ltd.

PRESS RELEASE

published on 12/20/2024 at 15:15, 1 year 3 months ago

Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
Quantum BioPharma Ltd. purchases $1,000,000 Bitcoin and other cryptocurrencies, allows cryptocurrency transactions, emphasizing compliance and potential returns for shareholders

Bitcoin Compliance Investment Cryptocurrency Quantum BioPharma
BRIEF

published on 12/14/2024 at 01:05, 1 year 3 months ago

Quantum BioPharma conclut la première tranche de son offre

Première Tranche Biopharmacie Quantique Unités D'obligations Développement Du Capital Dollars Canadiens
BRIEF

published on 12/14/2024 at 01:05, 1 year 3 months ago

Quantum BioPharma Concludes Initial Tranche of Offering

First Tranche Capital Development Quantum BioPharma Canadian Dollars Debenture Units
PRESS RELEASE

published on 12/14/2024 at 01:00, 1 year 3 months ago

Quantum Biopharma Announces Closing of First Tranche
Quantum BioPharma closes initial tranche of offering, issuing 500 Debenture Units for $500,000. Proceeds for business development and working capital. Securities subject to statutory hold period

Working Capital Statutory Hold Period Quantum BioPharma Debenture Units Tranche Offering
BRIEF

published on 12/10/2024 at 13:35, 1 year 3 months ago

Quantum Biopharma avance dans l'essai clinique Lucid-MS

Recherche Biopharmaceutique Biopharmacie Quantique Examen De Sécurité Essai Lucid-MS Progrès Clinique
BRIEF

published on 12/10/2024 at 13:35, 1 year 3 months ago

Quantum Biopharma Moves Forward in Lucid-MS Clinical Trial

Biopharmaceutical Research Quantum BioPharma Lucid-MS Trial Clinical Advancement Safety Review
PRESS RELEASE

published on 12/10/2024 at 13:30, 1 year 3 months ago

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
Quantum BioPharma announces approval to proceed with dosing of second cohort in Lucid-21-302 trial. Company focused on innovative treatments for neurodegenerative disorders

Drug Development Neurodegenerative Disorders Quantum BioPharma Lucid-21-302 Trial Safety Review Committee
BRIEF

published on 12/05/2024 at 13:35, 1 year 3 months ago

Quantum BioPharma Launches Private Placement for $5 Million

Private Placement Convertible Debenture Canadian Market Investment Offering Quantum BioPharma
BRIEF

published on 12/05/2024 at 13:35, 1 year 3 months ago

Quantum BioPharma lance un placement privé de 5 millions de dollars

Placement Privé Marché Canadien Obligation Convertible Biopharmacie Quantique Offre D'investissement
PRESS RELEASE

published on 12/05/2024 at 13:30, 1 year 3 months ago

Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million
Quantum BioPharma announces a non-brokered private placement offering of convertible debenture units. Proceeds for business development and working capital

Private Placement Working Capital Business Development Quantum BioPharma Debenture Units

Accesswire

Published on 04/02/2026 at 22:00, 22 hours 37 minutes ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 1 day 2 hours ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 5 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 5 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 6 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/03/2026 at 18:00, 2 hours 37 minutes ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 2 hours 37 minutes ago

IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 2 hours 52 minutes ago

Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 17:40, 2 hours 57 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.04.26.
Published on 04/03/2026 at 17:05, 3 hours 32 minutes ago

At WMF a new edition of AI Global Summit, an international reference point on Artificial Intelligence

Les Echos

Published on 04/03/2026 at 18:46, 1 hour 50 minutes ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 1 hour 50 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 2 hours 35 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 hours 37 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 hours 37 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026

View all LES ECHOS COMFI WIRE